Term
| Antimicrobials that affect primarily Gram Positives (G+) |
|
Definition
Penicillins
Cephalosporins (esp. early generations)
Bacitracin
Macrolides
Lincosamides
Rifamycin
Novobiocin |
|
|
Term
| Antimicrobials that affect primarily Gram Positives (G-) |
|
Definition
Ticarcillin (penicillin)
Cephalosporins (3rd generation)
Chloramphenicol/ Florfenicol
Aminoglycosides
Polymixin B
Fluoroquinolones |
|
|
Term
| Broad Spectrum antimicrobials |
|
Definition
Penicillins- Amoxi, Ampicillin, Clavamox
Cephlalosporins
Tetracyclines
Chloramphenicol/ Florfenicol
Sulfonamides
Fluoroquinolones |
|
|
Term
| Antimicrobial(s) that are not lipophilic |
|
Definition
Aminoglycosides
Penicillins |
|
|
Term
| Antimicrobial drugs that go intracellular |
|
Definition
Erythromycin
Enrofloxacin
Lincomycin and clindamycin (not active)
Doxycycline
Rifampin
Sulfa/trimethroprim |
|
|
Term
| Antimicrobials that are bacteriostatic |
|
Definition
Tetracycline
Chloramphenicol/ florfenicol
Macrolides
Lincosamides
Sulfonamides (not potentiated) |
|
|
Term
| Antimicrobials that are anti-Pseudomonal |
|
Definition
Ticracillin (penicillin family)
Piperacillin (penicillin family)
Imipenem (penicillin family)
Cephazolin (3rd gen. cephalosporin)
Cephtazidime (3rd gen. cephalosporin)
Polymixin B
Aminoglycosides (except Neomycin)
Fluorquinolones |
|
|
Term
| Extended Spectrum Beta Lactamases (ESBLs) |
|
Definition
susceptible to cefoxitin
resistant to ceftazidime
overcome by clavulanate |
|
|
Term
|
Definition
resistant to cefoxitin
resistant to ceftazidime
not overcome by clavulanate |
|
|
